MedPath

Investigating the solution containing herbal exosomes in comparison with Wharton jelly stem cell exosomes and 5% minoxidil in the treatment of hair loss.

Phase 1
Recruiting
Conditions
Hair Loss.
Nonscarring hair loss, unspecified
L65.9
Registration Number
IRCT20200127046282N53
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients aged 18 to 45 years
Hormonally healthy patients

Exclusion Criteria

Presence of evidence of sepsis, immunosuppression and cancer
Use of oral drug treatment for androgenic hair loss (such as finasteride, dutasteride or any other anti-androgen drug) in 12 months the past
Use of local drug treatment of androgenic hair loss (such as minoxidil, prostaglandin analogues, retinoids orCorticosteroids) in the last 12 months
Discovering another cause for the patient's hair loss
Non-cooperation of the patient until the end of the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath